Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_assertion type Assertion NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_head.
- NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_assertion description "[In the current study, we examined a panel of serially passaged glioblastoma xenografts, in the context of an intracranial tumor therapy response model, to identify associations between glioblastoma molecular characteristics and tumor sensitivity to the epidermal growth factor receptor (EGFR) kinase inhibitor erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_provenance.
- NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_assertion evidence source_evidence_literature NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_provenance.
- NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_assertion SIO_000772 17363510 NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_provenance.
- NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_assertion wasDerivedFrom befree-20140225 NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_provenance.
- NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_assertion wasGeneratedBy ECO_0000203 NP870697.RAI20OaZUogNtXftASES3TDaNN7kUDv9A3x5V2JZ79WK4130_provenance.